The average P/S ratio for CPRX's competitors is 46.16, providing a benchmark for relative valuation. Catalyst Pharmaceuticals Inc Corp (CPRX) exhibits a P/S ratio of 4.79, which is -89.61% above the industry average. Given its robust revenue growth of 43.56%, this premium appears sustainable.